AHCYL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.6807445152599E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.19899662315493E-11 |
Normal-vs-Stage2 |
9.315100E-03 |
Normal-vs-Stage3 |
1.6832091276342E-12 |
Normal-vs-Stage4 |
1.52829970900825E-10 |
Stage1-vs-Stage2 |
5.107600E-01 |
Stage1-vs-Stage3 |
1.535760E-01 |
Stage1-vs-Stage4 |
4.090600E-01 |
Stage2-vs-Stage3 |
2.380200E-01 |
Stage2-vs-Stage4 |
3.131200E-01 |
Stage3-vs-Stage4 |
7.870800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.66149341349364E-12 |
Normal-vs-AfricanAmerican |
1.58449919851478E-11 |
Normal-vs-Asian |
1.08769999673797E-08 |
Caucasian-vs-AfricanAmerican |
1.444560E-01 |
Caucasian-vs-Asian |
2.247800E-01 |
AfricanAmerican-vs-Asian |
8.478400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.13119957845242E-10 |
Normal-vs-Female |
1.62436730732907E-12 |
Male-vs-Female |
4.046100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.67232999999101E-05 |
Normal-vs-Age(41-60Yrs) |
1.99539995637821E-09 |
Normal-vs-Age(61-80Yrs) |
1.67621472257906E-12 |
Normal-vs-Age(81-100Yrs) |
1.26340000017322E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.221000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.895000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.789400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.979450E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.970100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.715600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.94180000026678E-07 |
Normal-vs-Grade 2 |
1.90359950025254E-11 |
Normal-vs-Grade 3 |
8.85003181849697E-12 |
Normal-vs-Grade 4 |
1.13770104448463E-11 |
Grade 1-vs-Grade 2 |
4.573800E-01 |
Grade 1-vs-Grade 3 |
4.302800E-01 |
Grade 1-vs-Grade 4 |
7.242400E-01 |
Grade 2-vs-Grade 3 |
9.428200E-01 |
Grade 2-vs-Grade 4 |
7.281000E-01 |
Grade 3-vs-Grade 4 |
6.811200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62536650805123E-12 |
Normal-vs-ccB subtype |
7.164800E-04 |
ccA subtype-vs-ccB subtype |
2.191900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.66409996893435E-09 |
Normal-vs-N1 |
2.28330000462407E-08 |
N0-vs-N1 |
9.063900E-02 |
|
|